Implant Sciences expands EU market share

Implant Sciences Corporation (OTCQB: IMSC) said it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market.

With this contract win, international airports in 11 EU countries have selected Implant Sciences´ QS-B220 since late April 2015, with orders totaling up to 883 units to such airports.

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives.

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate threats from explosives and drugs.